How will the Growth Unfold for Gastroesophageal Reflux Disease (GERD) Devices Market Leaders: Olympus Corporation, Pentax Medical, KARL STORZ SE & Co KG., Medtronic Plc, and Fujifilm Holdings Corporation

Gastroesophageal Reflux Disease (GERD) Devices Market: Boost in Adoption Expected in Clinics & Diagnostic Centers: Exceeding the revenue of US$ 1 billion in 2018, the global sales of gastroesophageal disease devices will witness a steady over 4% CAGR during 2018-2028. As indicated in a new intelligence outlook of Future Market Insights (FMI), esphagoscopes and gastroscopes will continue to account for most of the sales. Adoption of gastroesophageal reflux disease devices will remain maximum for diagnostic procedures, followed by fundoplication procedures.

More Patients Continue to Prefer GERD Devices over Lifestyle Modifications & PPIs: Besides the rapid expansion of geriatric population and elevating prevalence rate of obesity-driven gastroeasophageal reflux diseases, FMI in a new study states that the frequent intake of asthma medications is also a strong impact factor associated with the growth of gastroesophageal reflux disease devices market.

Key GERD Device Manufacturers Eyeing New Product Launches: The report tracks some of the key companies operating in the Gastroesophageal Reflux Disease Devices market, such as Olympus Corporation, Pentax Medical, Medtronic Plc., Diversatek Inc. The report also tracks the key manufacturers operating in gastroesophageal reflux disease treatment devices, such as EndoGastric Solutions, Medigus Ltd., Torax Medical, Inc. and Mederi RF, Inc.

Request to Download a Sample Copy of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1741

Although industry experts recommend lifestyle modifications as the most suitable remedy for gastroesophageal diseases, the growing demand for surgeries for obesity will continue to drive sales of gastroesophageal disease devices in coming years.

The second line of treatment for gastroesophageal reflux disease includes proton pump inhibitors (PPI) therapy, which can reduce the usage of gastroesophageal reflux disease devices. Proton pump inhibitors are the drugs that regulate acid production within stomach, and thereby restrict gastroesophageal reflux.

However, the proven side effects and functional failure of proton pump inhibitors in the long run will continue to benefit the demand for surgical treatment of gastroesophageal reflux disease, favoring the overall sales of gastroesophageal reflux disease devices such as PH monitoring system and manometry system.

Diagnostic Centers & Private Clinics to Employ More GERD Devices: While a majority of adoption of gastroesophageal reflux disease devices prevails in hospitals, the constantly increasing number of establishments in the ambulatory surgical center and diagnostic center segments is likely to translate into a higher rate of adoption of gastroesophageal reflux disease devices within the latter two.

With the number of diagnostic centers and private practice clinics on the constant rise, it is more likely that the demand for gastroesophageal reflux disease devices will observe steady growth over the years to come. Towards the end of forecast period, global market value share of clinics and diagnostic centers will be more than 35%, as suggested by FMI’s analysis of the gastroesophageal reflux disease devices market.

A majority of key manufacturers of gastroesophageal reflux disease devices are emphasizing new product launches. Innovation of new and advanced products is in turn shaping the growth of gastroesophageal reflux disease devices market.

Need More Details Information about Methodology @ https://www.futuremarketinsights.com/askus/rep-gb-1741

According to the report findings,

Olympus Corporation and Pentax Medical hold the maximum company share in the gastroesophageal reflux disease devices market.

Olympus Corporation recently launched an advanced version of esophagoscope and gastroscope.

Plc. and Diversatek, Inc. are the key players of diagnostic devices for gastroesophageal reflux disease, contributing a significant share in overall gastroesophageal reflux disease devices market.

EsophyX Z is the new and advanced version of EsophyX gastroesophageal reflux disease device, used for the transoral incisionless fundoplication process.

Gastroesophageal Reflux Diseases Devices Market Reports - Table of Contents
1. Executive Summary

1.1. Global Market Outlook

1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

4. Key Success Factors

4.1. Disease Epidemiology

4.2. Regulatory Scenario

5. Global Gastroesophageal Reflux Diseases Devices Market Pricing Analysis

5.1. Regional Pricing Analysis By Product Type

5.2. Pricing Break-up

5.2.1. Manufacturer Level Pricing

5.2.2. Distributor Level Pricing

5.3. Global Average Pricing Analysis Benchmark

6. Global Gastroesophageal Reflux Diseases Devices Market Demand (in Value or Size in US$ Mn) Analysis 2013-2017 and Forecast, 2018-2028

6.1. Historical Market Value (US$ Mn) Analysis, 2013-2017

6.2. Current and Future Market Value (US$ Mn) Projections, 2018-2028

6.2.1. Y-o-Y Growth Trend Analysis

6.2.2. Absolute $ Opportunity Analysis

7. Market Background

7.1. Macro-Economic Factors

7.1.1. Global GDP Growth Outlook

7.1.2. Global Healthcare Expenditure Outlook

7.1.3. Regional Healthcare Market Outlook

7.2. Forecast Factors - Relevance & Impact

7.2.1. Growing Adoption of Endoscopic Surgeries

7.2.2. Technological Advancements

7.2.3. Favourable Reimbursement Policies

7.2.4. Increasing Prevalence of Gastroesophageal Diseases

7.2.5. New Products Launches

7.3. Market Dynamics

7.3.1. Drivers

7.3.2. Restraints

7.3.3. Opportunity Analysis

8. Global Gastroesophageal Reflux Diseases Devices Market Analysis 2013-2017 and Forecast 2018-2028, by Product Type

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) and Analysis By Product Type, 2013 - 2017

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2018 - 2018

8.3.1. Diagnostic Devices

8.3.1.1. Manometry System

8.3.1.2. PH Monitoring System

8.3.2. Esophagoscopes and Gastroscopes

8.3.3. Treatment Devices

8.3.3.1. Ultrasonic Surgical Endostapler

8.3.3.2. Fundoplication Devices

8.3.3.3. Sphincter Augmentation Devices

8.3.3.4. Radiofrequency Ablation Devices

Request to Browse Report Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1741

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Blog: http://keepfacts.com/

Web: https://www.futuremarketinsights.com/

This release was published on openPR.